Table 1.
Parameters | |
---|---|
Number | 85 |
Age (years) | 48.6 ± 12.6 |
Sex, male/female | 64/21 |
Diabetes history (months) | 120 (60, 168) |
Proteinuria (g/24 h) | 4.0 (2.3, 7.6) |
uACR (mg/g) | 3223.6 (1691.3, 5837.5) |
Scr (μmol/L) | 174.3 (105.0, 309.9) |
BUN (mmol/L) | 11.2 (7.7, 15.4) |
eGFR (mL/min/1.73 m2) | 37.2 (20.3, 61.9) |
eGFR slope (mL/min/1.73 m2/year) | -5.8 (-6.0, -4.8) |
FBG, mmol/L | 6.5 (5.5,8.5) |
HbA1c (%) | 6.8 (5.8, 8.0) |
Hb (g/L) | 111.0 ± 23.2 |
Serum albumin (g/L) | 32.8 ± 6.0 |
TG (mmol/L) | 1.7 (1.2, 2.6) |
HDL-C (mmol/L) | 1.0 (0.8, 1.2) |
LDL-C (mmol/L) | 2.8 (2.0, 3.7) |
Pathological type, I/II/III/IV | 5/14/60/6 |
IFTA score, grade 0/1/2/3 | 0/20/24/41 |
Inflammation score, grade 0/1/2 | 0/33/52 |
Arteriole hyalinosis score, grade 0/1/2 | 22/63/0 |
Atherosclerosis score, grade 0/1/2 | 3/49/33 |
RAAS inhibitors (%) | 70.6 (60/85) |
Lipid-lowering drugs (%) | 57.6 (49/85) |
BUN: blood urea nitrogen; DKD: diabetic kidney disease; eGFR: estimated glomerular filtration rate; FBG: fasting blood glucose; Hb: hemoglobin; HbA1c: hemoglobin A1c; HDL-C: high-density lipoprotein-cholesterol; IFTA: interstitial fibrosis and tubular atrophy; LDL-C: low-density lipoprotein-cholesterol; RAAS: renin-angiotensin-aldosterone system; Scr: serum creatinine; TG: triglyceride; uACR: urinary albumin-to-creatinine ratio. The continuous data were expressed as mean ± SD or median and IQR as appropriate.